About ChromaCon
ChromaCon is a Healthcare company based in Zurich (Switzerland) founded in 2006, and was acquired by YMC in April 2019. Proprietary chromatographic process technology and equipment are developed. Its chief executive, as recorded, is Michael Bavand. ChromaCon offers products and services including Contichrom CUBE, Contichrom TWIN, YMC Columns and Resins, MCSGP, and CaptureSMB. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its legal entity is ChromaCon AG.
Company details
ChromaCon was founded in 2006 in Zurich, Switzerland, with operations centered on the biotechnology sector. Proprietary chromatographic process technology is developed, alongside specialized equipment for purification applications. Key products include FPLC systems such as Contichrom CUBE, Contichrom HPLC, Contichrom Discovery, Contichrom C, and GMP Scale-Up Equipment. Collaborations are established with partners including Bargal, YMC, HE, and BCM. The company is led by CEO Michael Bavand.
- Headquarters Zurich, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website chromacon.com/en
- Social LinkedIn X
- Acquired by YMC (Apr 2019)
- Legal Name Chromacon Ag
Products & Services of ChromaCon
ChromaCon offers a comprehensive portfolio of products and services, including Contichrom CUBE, Contichrom TWIN, YMC Columns and Resins, MCSGP, and CaptureSMB.
Lab-scale system for biomolecule development and production processes.
Twin-column system for pilot-scale purification and manufacturing.
Products for analytical and preparative-scale HPLC applications.
Automated continuous polishing process for biopharmaceutical yields.
Continuous capture process to optimize protein purification.
Investors in ChromaCon
ChromaCon has secured backing from 1 investor. Prominent investors backing the company include YMC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Synthetic microspheres are manufactured for industrial applications by YMC. | 1980 | ymc.co.jp | Kyoto, Japan |
Investor details for ChromaCon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ChromaCon
1 people are tracked at ChromaCon (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Bavand | CEO | Leadership |
Complete people profiles for ChromaCon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ChromaCon
2 dated milestones of ChromaCon across 13 years, from founding to its latest funding, stage changes and deals.
- Founded ChromaCon is founded.
- Exit Acquired by YMC.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chromacon
Complete news archive for ChromaCon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChromaCon
ChromaCon was founded in 2006.
ChromaCon is headquartered in Zurich, Switzerland.
Michael Bavand is the CEO of ChromaCon, as recorded in our data.
ChromaCon was founded in 2006 in Zurich, Switzerland, with operations centered on the biotechnology sector. Proprietary chromatographic process technology is developed, alongside specialized equipment for purification applications. Key products include FPLC systems such as Contichrom CUBE, Contichrom HPLC, Contichrom Discovery, Contichrom C, and GMP Scale-Up Equipment. Collaborations are established with partners including Bargal, YMC, HE, and BCM. The company is led by CEO Michael Bavand.
ChromaCon offers Contichrom CUBE, Contichrom TWIN, YMC Columns and Resins, MCSGP, and CaptureSMB.
ChromaCon has 1 investor. Key investors include YMC.
ChromaCon operates through Chromacon Ag.
Yes. ChromaCon was acquired by YMC in April 2019.